FDA.reportPublic FDA data

liothyronine sodium 0.05 MG Oral Tablet [Liomny]

RxCUI
2723583
RxNorm name
liothyronine sodium 0.05 MG Oral Tablet [Liomny]
Display name
liothyronine sodium 0.05 MG Oral Tablet [Liomny]
Full name
liothyronine sodium 0.05 MG Oral Tablet [Liomny]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:38:47

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
LiomnyLIOTHYRONINE SODIUMSIGMAPHARM LABORATORIES, LLC0dcec611-2b7a-4cf3-80c3-7389be2f0a942025-11-21Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2723583

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
0dcec611-2b7a-4cf3-80c3-7389be2f0a94LIOMNY 50 MCG Oral Tablet [PSN] · liothyronine sodium 0.05 MG Oral Tablet [Liomny] [SBD] · Liomny 50 MCG Oral Tablet [SY]36These highlights do not include all the information needed to use LIOMNY safely and effectively. See full prescribing information for LIOMNY. LIOMNY TM (liothyronine sodium tablets, USP), for oral use Initial U.S. Approval: 195620251121